A PROMIS Measure of Neuropathic Pain Quality

Robert L. Askew, Karon F. Cook, Francis J. Keefe, Cindy J. Nowinski, David Cella, Dennis A. Revicki, Esi M. Morgan DeWitt, Kaleb D Michaud, Dace L. Trence, Dagmar Amtmann

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives Neuropathic pain (NP) is a consequence of many chronic conditions. This study aimed to develop an unidimensional NP scale with scores that represent levels of NP and distinguish between individuals with NP and non-NP conditions. Methods A candidate item pool of 42 pain quality descriptors was administered to participants with osteoarthritis, rheumatoid arthritis, diabetic neuropathy, and cancer chemotherapy-induced peripheral neuropathy. A subset of pain quality descriptors (items) that best distinguished between participants with and those without NP conditions were identified. Dimensionality of pain descriptors was evaluated in a development sample and cross-validated in a holdout sample. Item responses were calibrated using an item response theory model, and scores were generated on a T-score metric. NP scale scores were evaluated in terms of the reliability, validity, and ability to distinguish between participants with and without conditions typically associated with NP. Results Of the 42 initial items, 5 were identified for the Patient-Reported Outcome Measurement Information System (PROMIS) Neuropathic Pain Quality Scale. T scores exhibited good discriminatory ability on the basis of receiver-operator characteristic analysis. Score thresholds that optimize sensitivity and specificity were identified. Construct, criterion, and discriminant validity, and reliability of scale scores were supported. Conclusions The five-item Patient-Reported Outcome Measurement Information System (PROMIS PQ-Neuro) Neuropathic Pain Quality Scale is a short and practical measure that can be used to identify patients more likely to have NP and to distinguish levels of NP. The data collected will support future research that targets other unidimensional pain quality domains (e.g., nociceptive pain).

Original languageEnglish (US)
Pages (from-to)623-630
Number of pages8
JournalValue in Health
Volume19
Issue number5
DOIs
StatePublished - Jul 1 2016

Fingerprint

Neuralgia
Information Systems
Pain
Aptitude
Reproducibility of Results
Patient Reported Outcome Measures
Nociceptive Pain
Diabetic Neuropathies
Peripheral Nervous System Diseases
Osteoarthritis
Rheumatoid Arthritis
Drug Therapy
Sensitivity and Specificity

Keywords

  • PROMIS
  • measurement
  • neuropathy
  • pain
  • patient-reported outcomes

ASJC Scopus subject areas

  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Askew, R. L., Cook, K. F., Keefe, F. J., Nowinski, C. J., Cella, D., Revicki, D. A., ... Amtmann, D. (2016). A PROMIS Measure of Neuropathic Pain Quality. Value in Health, 19(5), 623-630. https://doi.org/10.1016/j.jval.2016.02.009

A PROMIS Measure of Neuropathic Pain Quality. / Askew, Robert L.; Cook, Karon F.; Keefe, Francis J.; Nowinski, Cindy J.; Cella, David; Revicki, Dennis A.; Morgan DeWitt, Esi M.; Michaud, Kaleb D; Trence, Dace L.; Amtmann, Dagmar.

In: Value in Health, Vol. 19, No. 5, 01.07.2016, p. 623-630.

Research output: Contribution to journalArticle

Askew, RL, Cook, KF, Keefe, FJ, Nowinski, CJ, Cella, D, Revicki, DA, Morgan DeWitt, EM, Michaud, KD, Trence, DL & Amtmann, D 2016, 'A PROMIS Measure of Neuropathic Pain Quality', Value in Health, vol. 19, no. 5, pp. 623-630. https://doi.org/10.1016/j.jval.2016.02.009
Askew RL, Cook KF, Keefe FJ, Nowinski CJ, Cella D, Revicki DA et al. A PROMIS Measure of Neuropathic Pain Quality. Value in Health. 2016 Jul 1;19(5):623-630. https://doi.org/10.1016/j.jval.2016.02.009
Askew, Robert L. ; Cook, Karon F. ; Keefe, Francis J. ; Nowinski, Cindy J. ; Cella, David ; Revicki, Dennis A. ; Morgan DeWitt, Esi M. ; Michaud, Kaleb D ; Trence, Dace L. ; Amtmann, Dagmar. / A PROMIS Measure of Neuropathic Pain Quality. In: Value in Health. 2016 ; Vol. 19, No. 5. pp. 623-630.
@article{a7036b96016041df9e03894ed6f35b3b,
title = "A PROMIS Measure of Neuropathic Pain Quality",
abstract = "Objectives Neuropathic pain (NP) is a consequence of many chronic conditions. This study aimed to develop an unidimensional NP scale with scores that represent levels of NP and distinguish between individuals with NP and non-NP conditions. Methods A candidate item pool of 42 pain quality descriptors was administered to participants with osteoarthritis, rheumatoid arthritis, diabetic neuropathy, and cancer chemotherapy-induced peripheral neuropathy. A subset of pain quality descriptors (items) that best distinguished between participants with and those without NP conditions were identified. Dimensionality of pain descriptors was evaluated in a development sample and cross-validated in a holdout sample. Item responses were calibrated using an item response theory model, and scores were generated on a T-score metric. NP scale scores were evaluated in terms of the reliability, validity, and ability to distinguish between participants with and without conditions typically associated with NP. Results Of the 42 initial items, 5 were identified for the Patient-Reported Outcome Measurement Information System (PROMIS) Neuropathic Pain Quality Scale. T scores exhibited good discriminatory ability on the basis of receiver-operator characteristic analysis. Score thresholds that optimize sensitivity and specificity were identified. Construct, criterion, and discriminant validity, and reliability of scale scores were supported. Conclusions The five-item Patient-Reported Outcome Measurement Information System (PROMIS PQ-Neuro) Neuropathic Pain Quality Scale is a short and practical measure that can be used to identify patients more likely to have NP and to distinguish levels of NP. The data collected will support future research that targets other unidimensional pain quality domains (e.g., nociceptive pain).",
keywords = "PROMIS, measurement, neuropathy, pain, patient-reported outcomes",
author = "Askew, {Robert L.} and Cook, {Karon F.} and Keefe, {Francis J.} and Nowinski, {Cindy J.} and David Cella and Revicki, {Dennis A.} and {Morgan DeWitt}, {Esi M.} and Michaud, {Kaleb D} and Trence, {Dace L.} and Dagmar Amtmann",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.jval.2016.02.009",
language = "English (US)",
volume = "19",
pages = "623--630",
journal = "Value in Health",
issn = "1098-3015",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - A PROMIS Measure of Neuropathic Pain Quality

AU - Askew, Robert L.

AU - Cook, Karon F.

AU - Keefe, Francis J.

AU - Nowinski, Cindy J.

AU - Cella, David

AU - Revicki, Dennis A.

AU - Morgan DeWitt, Esi M.

AU - Michaud, Kaleb D

AU - Trence, Dace L.

AU - Amtmann, Dagmar

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Objectives Neuropathic pain (NP) is a consequence of many chronic conditions. This study aimed to develop an unidimensional NP scale with scores that represent levels of NP and distinguish between individuals with NP and non-NP conditions. Methods A candidate item pool of 42 pain quality descriptors was administered to participants with osteoarthritis, rheumatoid arthritis, diabetic neuropathy, and cancer chemotherapy-induced peripheral neuropathy. A subset of pain quality descriptors (items) that best distinguished between participants with and those without NP conditions were identified. Dimensionality of pain descriptors was evaluated in a development sample and cross-validated in a holdout sample. Item responses were calibrated using an item response theory model, and scores were generated on a T-score metric. NP scale scores were evaluated in terms of the reliability, validity, and ability to distinguish between participants with and without conditions typically associated with NP. Results Of the 42 initial items, 5 were identified for the Patient-Reported Outcome Measurement Information System (PROMIS) Neuropathic Pain Quality Scale. T scores exhibited good discriminatory ability on the basis of receiver-operator characteristic analysis. Score thresholds that optimize sensitivity and specificity were identified. Construct, criterion, and discriminant validity, and reliability of scale scores were supported. Conclusions The five-item Patient-Reported Outcome Measurement Information System (PROMIS PQ-Neuro) Neuropathic Pain Quality Scale is a short and practical measure that can be used to identify patients more likely to have NP and to distinguish levels of NP. The data collected will support future research that targets other unidimensional pain quality domains (e.g., nociceptive pain).

AB - Objectives Neuropathic pain (NP) is a consequence of many chronic conditions. This study aimed to develop an unidimensional NP scale with scores that represent levels of NP and distinguish between individuals with NP and non-NP conditions. Methods A candidate item pool of 42 pain quality descriptors was administered to participants with osteoarthritis, rheumatoid arthritis, diabetic neuropathy, and cancer chemotherapy-induced peripheral neuropathy. A subset of pain quality descriptors (items) that best distinguished between participants with and those without NP conditions were identified. Dimensionality of pain descriptors was evaluated in a development sample and cross-validated in a holdout sample. Item responses were calibrated using an item response theory model, and scores were generated on a T-score metric. NP scale scores were evaluated in terms of the reliability, validity, and ability to distinguish between participants with and without conditions typically associated with NP. Results Of the 42 initial items, 5 were identified for the Patient-Reported Outcome Measurement Information System (PROMIS) Neuropathic Pain Quality Scale. T scores exhibited good discriminatory ability on the basis of receiver-operator characteristic analysis. Score thresholds that optimize sensitivity and specificity were identified. Construct, criterion, and discriminant validity, and reliability of scale scores were supported. Conclusions The five-item Patient-Reported Outcome Measurement Information System (PROMIS PQ-Neuro) Neuropathic Pain Quality Scale is a short and practical measure that can be used to identify patients more likely to have NP and to distinguish levels of NP. The data collected will support future research that targets other unidimensional pain quality domains (e.g., nociceptive pain).

KW - PROMIS

KW - measurement

KW - neuropathy

KW - pain

KW - patient-reported outcomes

UR - http://www.scopus.com/inward/record.url?scp=84962467338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962467338&partnerID=8YFLogxK

U2 - 10.1016/j.jval.2016.02.009

DO - 10.1016/j.jval.2016.02.009

M3 - Article

C2 - 27565279

AN - SCOPUS:84962467338

VL - 19

SP - 623

EP - 630

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - 5

ER -